{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04626",
      "entity_text" : "HER2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0964" ],
      "Organ" : [ "uberon:UBERON:0002042" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "Trastuzumab targets to HER2, which is overexpressed in around 30% of breast cancer patients and confers a significantly worse prognosis.",
  "reading_complete" : "2020-08-03T13:13:07Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:12:04Z",
  "trigger" : "overexpressed",
  "evidence" : [ "HER2, which is overexpressed" ],
  "pmc_id" : "5196893",
  "score" : 0
}